Tag: raw materials

Analysis of Test Method Non-Compliance Risks Encountered During Inspections Test method non-compliance can be a significant challenge for pharmaceutical manufacturers, especially when undergoing regulatory inspections by authorities such as the…

Implementing Justification Strategies for In-House Specifications During Regulatory Submissions In the realm of pharmaceutical manufacturing, the challenge of justifying in-house specifications during submission support is a complex issue that can…

Understanding Test Method Non-Compliance During Supplier Qualification to Prevent Repeat Incidents In the realm of pharmaceutical manufacturing, non-compliance with testing methods during supplier qualification can lead to significant quality risks,…

Preventing Recurrences of Outdated Pharmacopoeial Monographs During Supplier Qualification In the pharmaceutical manufacturing landscape, the integrity of raw materials is paramount. Utilizing outdated pharmacopoeial monographs during the supplier qualification process…

Audit Review Challenges: Addressing Specification Harmonization Issues For pharmaceutical professionals, encountering discrepancies in specifications during audit reviews can be a significant challenge. Such deviations can compromise product quality, facilitate regulatory…

Investigating the Risks of Using Outdated Pharmacopoeial Monographs in Submission Support Pharmaceutical manufacturers often face significant compliance challenges, particularly when relying on outdated pharmacopoeial monographs during submission support. This issue…

Identifying Compliance Gaps from Unimplemented Pharmacopoeial Changes During Audits In a highly regulated pharmaceutical environment, adherence to pharmacopoeial standards (USP, EP, IP) is paramount to ensure product quality and patient…

Compliance Gaps from Using Outdated Pharmacopoeial Monographs in Supplier Qualifications In the highly regulated pharmaceutical landscape, the utilization of outdated pharmacopoeial monographs during supplier qualification can potentially lead to compliance…

Strategies for Justifying Unimplemented Pharmacopoeial Changes During Inspection In pharmaceutical manufacturing, adherence to established pharmacopoeial standards is critical for maintaining the quality and safety of raw materials, especially APIs and…